Interlace Medical Inc Obtains $20,500,000 Series C Funding Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=2ea73d3a-5d8b-4883-b46c-7a1b8d3d79c0&Preview=1 -
Date
6/15/2009 -
Company Name
Interlace Medical Inc -
Mailing Address
139 Newbury Street Framingham, MA 01701 -
Company Description
Interlace’s mission is to improve the lives of women by delivering the most advanced medical devices in the world for treating gynecological diseases and conditions.Organized in 2006, Interlace Medical, Inc. is focused on designing and developing devices for the Interventional Gynecologist to perform office-based procedures to treat diseases and conditions traditionally requiring surgery in the operating room. Until recently, office-based procedural growth has been hampered by the lack of technology and reimbursement. In recent years several office-based gynecology procedures have received favorable reimbursement rates (Sterilization and Endometrial Ablation). Nonetheless, a need persists for safer, less invasive gynecology procedures that can be performed in an office setting. -
Website
http://www.interlacemedical.com/ -
Transaction Type
Venture Equity -
Transaction Amount
$20,500,000 -
Transaction Round
Series C -
Proceeds Purposes
The proceeds will be used to begin commercialization of the MyoSure™ system, an easy-to-use, minimally invasive treatment to remove intrauterine fibroids and polyps. -
M&A Terms
-
Venture Investor
Baird Venture Partners -
Venture Investor
HLM Venture Partners -
Venture Investor
Hambrecht & Quist Capital Management -
Venture Investor
Aperture Venture Partners -
Venture Investor
New Leaf Venture Partners -
Venture Investor
Spray Venture Partners
